Literature DB >> 6103157

Danger of withdrawal of vasodilator therapy in patients with chronic heart-failure.

S P Hanley, A Cowley, J R Hampton.   

Abstract

Ten patients with severe congestive heart-failure were treated with a vasodilator, prazosin, in addition to diuretics; their exercise capacity was assessed by testing on a treadmill. After the withdrawal of prazosin the condition of three patients deteriorated markedly.

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 6103157     DOI： 10.1016/s0140-6736(80)91232-5

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


  4 in total

1.  Vasodilators in heart failure.

Authors:  A Breckenridge
Journal:  Br Med J (Clin Res Ed)       Date:  1982-03-13

Review 2.  The treatment of heart failure. A methodological review of the literature.

Authors:  G H Guyatt
Journal:  Drugs       Date:  1986-12       Impact factor: 9.546

3.  The central haemodynamic effects of a single intravenous dose of flosequinan in patients with severe heart failure.

Authors:  H Markus; A J Cowley
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

Review 4.  Prazosin update. A review of its pharmacological properties and therapeutic use in hypertension and congestive heart failure.

Authors:  W F Stanaszek; D Kellerman; R N Brogden; J A Romankiewicz
Journal:  Drugs       Date:  1983-04       Impact factor: 9.546
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.